Company / PP&E per Share
Seres Therapeutics, Inc. PP&E per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.88
FY2025
5-year range
$0.18 / $0.88
FY2021-FY2025
Trend
+380.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share changed +381% YoY in FY2025, a notable deviation from the 9-year average annual change of +27%.
Based on SEC 10-K filings.
0.88 in FY2025 with a 10-year CAGR of -2.4%.
Improved from $0.25 to $0.88 over the past 3 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +52.2%
- 5-Year CAGR
- +34.8%
- 10-Year CAGR
- -2.4%
Key checks
Key Insights
- In FY2025, pp&e per share increased 380.9% year-over-year.
- Peak pp&e per share was recorded in FY2015.
- Lowest pp&e per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.88 | +380.9% |
| FY2023 | $0.18 | -26.6% |
| FY2022 | $0.25 | +27.5% |
| FY2021 | $0.20 | -1.0% |
| FY2020 | $0.20 | -58.4% |
| FY2019 | $0.48 | -26.5% |
| FY2018 | $0.65 | -20.6% |
| FY2017 | $0.82 | -11.7% |
| FY2016 | $0.92 | -17.8% |
| FY2015 | $1.12 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026